LFG
FBIO icon

Larson Financial Group’s Fortress Biotech FBIO Stock Holding History

Larson Financial Group’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113 Sell
37
-30
-45% -$77 ﹤0.01% 3645
2026
Q1 		$187 Buy
67
+51
+319% +$173 ﹤0.01% 3460
2025
Q4 		$59 Buy
+16
New +$46 ﹤0.01% 3372

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Larson Financial Group's FBIO Position: Q2 2026 in Review

Larson Financial Group reduced its Fortress Biotech (FBIO) stake by 45% in Q2 2026, selling an estimated $77 and leaving 37 shares worth $113. The position accounts for ﹤0.01% of the portfolio, ranked #3645.

Larson Financial Group first reported a position in FBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $187 in Q1 2026. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Larson Financial Group held 37 shares of Fortress Biotech worth $113 as of Q2 2026.
  • Larson Financial Group sold 30 Fortress Biotech shares in Q2 2026, an estimated $77.
  • Fortress Biotech made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3645 holding.
  • Larson Financial Group first reported a position in Fortress Biotech in Q4 2025 and has held it in 3 quarters since.
  • Larson Financial Group's Fortress Biotech position peaked at $187 in Q1 2026.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.